Wake Forest Baptist Health, Medical Intensive Care Unit
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Morris, Peter
NICEGUT, NCT02165813: Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children

Terminated
2/3
216
RoW
Nitazoxanide, Alinia, placebo
Telethon Kids Institute, The University of Western Australia, Menzies School of Health Research
Gastroenteritis
04/21
06/21
NCT05496868 / 2022-001612-25: Add-on Reparixin in Adult Patients With ARDS

Recruiting
2
66
Europe, US
Reparixin 600mg, REP, Matching Placebo, Control
Dompé Farmaceutici S.p.A, Dompè farmaceutici s.p.a.
Acute Respiratory Distress Syndrome, Adult
08/25
08/25
HfLI, NCT03916029: Hearing for Learning Initiative - a Health Facilitator Model for Otitis Media

Active, not recruiting
N/A
18
RoW
facilitator
Menzies School of Health Research, Australian Government Department of Health and Ageing, Northern Territory Government of Australia
Otitis Media, Conductive Hearing Loss
06/24
12/24
NCT05912413: Predicton of Sepsis Recovery Performance Subtypes Pilot Study

Recruiting
N/A
40
US
there is no intervention
University of Alabama at Birmingham
Sepsis
10/25
10/25
REMM-HIIT-CoV, NCT05218083: REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

Recruiting
N/A
120
US
REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training (REMM-HIIT)
Duke University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Vanderbilt University Medical Center, Ohio State University, University of Kentucky, University of Alabama at Birmingham, Florida Atlantic University
COVID-19, Critical Illness, ICU Acquired Weakness, PICS, Cardiorespiratory Fitness
08/26
11/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Morris, Peter
NICEGUT, NCT02165813: Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children

Terminated
2/3
216
RoW
Nitazoxanide, Alinia, placebo
Telethon Kids Institute, The University of Western Australia, Menzies School of Health Research
Gastroenteritis
04/21
06/21
NCT05496868 / 2022-001612-25: Add-on Reparixin in Adult Patients With ARDS

Recruiting
2
66
Europe, US
Reparixin 600mg, REP, Matching Placebo, Control
Dompé Farmaceutici S.p.A, Dompè farmaceutici s.p.a.
Acute Respiratory Distress Syndrome, Adult
08/25
08/25
HfLI, NCT03916029: Hearing for Learning Initiative - a Health Facilitator Model for Otitis Media

Active, not recruiting
N/A
18
RoW
facilitator
Menzies School of Health Research, Australian Government Department of Health and Ageing, Northern Territory Government of Australia
Otitis Media, Conductive Hearing Loss
06/24
12/24
NCT05912413: Predicton of Sepsis Recovery Performance Subtypes Pilot Study

Recruiting
N/A
40
US
there is no intervention
University of Alabama at Birmingham
Sepsis
10/25
10/25
REMM-HIIT-CoV, NCT05218083: REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

Recruiting
N/A
120
US
REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training (REMM-HIIT)
Duke University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Vanderbilt University Medical Center, Ohio State University, University of Kentucky, University of Alabama at Birmingham, Florida Atlantic University
COVID-19, Critical Illness, ICU Acquired Weakness, PICS, Cardiorespiratory Fitness
08/26
11/26

Download Options